Developed by a working group of experts, led by the Wellcome Trust, the Stewardship and Access Plan (SAP) Development Guide is a crucial resource in the fight against Antimicrobial Resistance (AMR). It equips pharmaceutical companies and product developers with practical steps to expedite access to new antibacterial products while maintaining responsible usage practices.
Hosted on the on the CARB-X website,the SAP Development Guide is a tool that empowers companies to expand their stewardship and access plans. It captures expert input, including from the Access to Medicine Foundation, on the early actions companies can take to accelerate access and stewardship for new antibacterials, diagnostics and preventatives. The guide is a valuable supplementary resource aimed at enhancing the quantity and quality of such plans, ensuring accessibility for low- and middle-income countries. It can be used by the full range of companies engaged in developing antimicrobial products – from large research-based pharmaceutical companies, to small and medium sized enterprises (SMEs).Â
The Access to Medicine Foundation has been working to incentivise pharma companies to develop stewardship and access plans since 2016. We are confident that this new guide will further support companies in making advance planning a priority to protect the effectiveness of antibiotic candidates." - Jayasree K. Iyer, Executive Director of the Access to Medicine Foundation.
Jayasree K. Iyer
CEO, Access to Medicine Foundation
What is included in the guide?
Insights into the significance of comprehensive advance planning Â
An overview of the essential elements of stewardship and access plans Â
Detailed components that product developers may incorporate into their plans Â
Real-world examples of diverse approaches to enhance access, including registration, licensing, equitable pricing strategies, and supply considerations Â
Resources for product developers seeking further guidanceÂ
